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Fate decisionDuring vertebrate development, neural crest cells are exposed to multiple extracellular cues that drive
their differentiation into neural and non-neural cell lineages. Insights into the signals potentially
involved in neural crest cell fate decisions in vivo have been gained by cell culture experiments that have
allowed the identiﬁcation of instructive growth factors promoting either proliferation of multipotent
neural crest cells or acquisition of speciﬁc fates. For instance, members of the TGFβ factor family induce
neurogenesis and smooth muscle cell formation at the expense of other fates in culture. In vivo,
conditional ablation of various TGFβ signaling components resulted in malformations of non-neural
derivatives of the neural crest, but it is unclear whether these phenotypes involved aberrant fate
decisions. Moreover, it remains to be shown whether neuronal determination indeed requires TGFβ
factor activity in vivo. To address these issues, we conditionally deleted Smad4 in the neural crest, thus
inactivating all canonical TGFβ factor signaling. Surprisingly, neural crest cell fates were not affected in
these mutants, with the exception of sensory neurogenesis in trigeminal ganglia. Rather, Smad4
regulates survival of smooth muscle and proliferation of autonomic and ENS neuronal progenitor cells.
Thus, Smad signaling plays multiple, lineage-speciﬁc roles in vivo, many of which are elicited only after
neural crest cell fate decision.
© 2009 Elsevier Inc. All rights reserved.Introduction
During development, multipotent cells have to proliferate and
adopt particular fates at the correct time and location to give rise to an
appropriate number of differentiated cell types. A good example for
this are neural crest cells that generate a variety of specialized cell
types in vertebrates, including peripheral glia, sensory and autonomic
neurons of the peripheral nervous system (PNS), the enteric nervous
system (ENS), as well as pigment cells, smooth muscle in the
cardiovascular system, and craniofacial chondrocytes and osteoblasts
(reviewed in Le Douarin and Dupin, 2003). Studies performed with
cultures of migratory and postmigratory neural crest cells have shed
light on some of the growth factors, signaling pathways, and
transcriptional programs that control neural crest cell fate decisions
(reviewed in Delﬁno-Machin et al., 2007; Fuchs and Sommer, 2007).
In particular, clonal cell culture assays revealed that certain growth
factors have the capacity to instruct neural crest-derived stem cells
(NCSCs) to adopt speciﬁc fates at the expense of other fates. However,
to date only few of these signals have been demonstrated to indeed
inﬂuence neural crest cell fate decisions in vivo. One exception to thismmer).
l rights reserved.is represented by Wnt/β-catenin signaling that instructs migratory
NCSCs to adopt a sensory fate in culture and that is both required for
sensory neurogenesis and sufﬁcient upon constitutive activation to
promote this fate in vivo at the expense of other neural as well as non-
neural fates (Hari et al., 2002; Lee et al., 2004). In contrast, neuregulin
and Notch induce glial fates in cultured NCSCs, but inactivation of
these signals still allows the formation of at least some peripheral glial
lineages in vivo (reviewed in Woodhoo and Sommer, 2008).
Incubation of NCSCs in cultures with members of the TGFβ factor
family, such as TGFβ1, 2 and 3 as well as BMP2 and 4, fosters either
generation of sensory neurons, autonomic neurons or smooth muscle,
or induces apoptosis, depending on the cellular context and the
concentration of the factors (Shah et al., 1996; Hagedorn et al., 1999,
2000; Lo et al., 2002; Ota and Ito, 2006). Ligands of the TGFβ factor
family signal by bringing together two pairs of type I and type II
receptors, respectively (Massague, 2008). There are different type I
and II receptors that can interact with a set of distinct co-receptors,
adding to the signaling complexity. Activation of these serine/
threonine kinase receptors leads to signal propagation by phosphory-
lation of Receptor-Smads (R-Smad) transcription factors, with Smads
2 and 3 mediating the activities of TGFβ isoforms, activins, and other
ligands, and Smads 1, 5, and 8 the activities of BMPs and others. Once
activated, R-Smads translocate to the nucleus to interact with Smad4,
which is common to both TGFβ and BMP signaling pathways. This
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canonical TGFβ factor signaling. Non-canonical signaling can also
occur, however, and involves Smad4-independent R-Smad signaling
as well as Smad-independent receptor type I or II signaling.
Several of the above mentioned signaling components have been
manipulated in vivo in the developing neural crest (Wurdak et al.,
2006). With respect to TGFβ family ligands, inactivation of genes
encoding TGFβ2 and TGFβ3 in mice resulted in severe craniofacial
malformations, while BMP overexpression or blocking BMP by its
inhibitor Noggin in developing chicken affected sympathetic ganglia
formation (Reissmann et al., 1996; Schneider et al., 1999; Dunker and
Krieglstein, 2002; Wurdak et al., 2006). With respect to receptors for
TGFβ family factors, TGFβ type II receptor (Tgbfr2) and TGFβ type I
receptor (Alk5) inactivation in the neural crest caused extensive
craniofacial defects, such as cleft palate, and cardiovascular mal-
formations including aortic arch patterning deﬁciencies, persistent
truncus arteriosus, and septal defects (Ito et al., 2003; Ittner et al.,
2005; Wurdak et al., 2005; Choudhary et al., 2006; Dudas et al., 2006;
Wang et al., 2006). Similar defects, although not as severe, resulted
from deletion of receptors mediating BMP responses (Dudas et al.,
2004; Kaartinen et al., 2004; Stottmann et al., 2004). Finally, ablation
of the downstream mediator of canonical TGFβ signaling, Smad4, led
to massive cell death and thus malformations in both craniofacial and
cardiovascular neural crest derivatives (Jia et al., 2007; Ko et al., 2007)
and to reduced size and altered patterning of trigeminal ganglia
(Hodge et al., 2007; Ko et al., 2007).
In view of the role of TGFβ factors in NCSC cultures, the question
arises of whether the abovementioned phenotypes are possibly
associated with failures in neural crest cell fate decisions in vivo.
Given the partially overlapping and therefore potentially compensa-
tory effects of TGFβ and BMP in neural crest cell cultures, we sought to
address this question by inactivation of Smad4 in neural crest cells,
hence preventing both canonical TGFβ and BMP signaling. Unexpect-
edly, canonical TGFβ factor signaling controls cell survival and
proliferation in a cell lineage-speciﬁc manner, and generation of a
trigeminal sensory sublineage, but appears not to be required for
smooth muscle and autonomic neuronal fate acquisition.
Materials and methods
Generation of mutant animals
The Cre/loxP system was used to conditionally delete the C-
terminal domain of the Smad4 protein (Yang et al., 2002) and to
inactivate the TGF-β type II receptor (Tgfbr2) (Leveen et al., 2002;
Wurdak et al., 2005). For a selective ablation in NCSCs the Wnt1-Cre
transgenic mouse line was used (Danielian et al., 1998). To obtain
Wnt1-Cre/Smad4lox/lox conditional knock out (mutant) embryos
Smad4lox/lox mice were mated with Wnt1-Cre/Smad4lox/wt mice.
Similar breedings were done to generate Wnt1-Cre/Tgfbr2lox/lox
conditional knock out (mutant) embryos. In vivo fate mapping of
neural crest cells was done by mating Wnt1-Cre/Smad4lox/wt mice
with Smad4lox/lox carrying the ROSA26 Cre reporter (R26R) allele
(Soriano, 1999). Genotyping was done on genomic DNA by PCR using
the primer pair 5′-GGC ACA TTA CAT TTG CAG TCA G-3′ and 5′-AGG
AAA AAC AGG GCT ATG TAG AA-3′ which gives a 282 bp fragment for
the Smad4wildtype allele and a 330 bp fragment for the ﬂoxed Smad4
allele. Genotyping for the Tgfbr2 ﬂoxed allele and Wnt1-Cre was done
as described in Hari et al. (2002) and Wurdak et al. (2005).
Staining procedures
E9.5–E11.5 embryos were ﬁxed in 4% PFA for 45 min to 2 h at room
temperature (RT) according to their developmental stage. In situ
hybridization on cryosections with digoxigenin-labeled probes and X-
Gal detection of LacZ gene expressionwere performed as described inHari et al. (2002). Programmed cell death detection was done by
TUNEL labeling (Roche) according to the manufacturer's manual.
Immunohistochemistry was performed on cryo or parafﬁn sections.
Antigen retrieval on parafﬁn sections was done in citrate buffer pH 6
in a steam cooker device (HistosPro, Milestone) at 110 °C. Cryosections
were ﬁxed for 10 min in 4% PFA before staining. Cells were ﬁxed in 4%
formaldehyde for 10min at RT. The following primary antibodies were
used: Rabbit anti-Smad4 (1:100, Abcam), mouse anti-SMA (1:400,
Sigma), mouse anti-β-Gal (1:100, Abcam), mouse anti-βIII-tubulin
(1:300, Sigma), mouse anti-TH (1:300, Boehringer Mannheim),
mouse anti-NF160 (1:500, Sigma), rat anti-Ki67 (1:50, DAKO),
mouse anti-Mash1 (1:100, BD Biosciences), mouse anti-Sox10
(1:100, R&D), rabbit anti-p75 (1:300, Sigma), rabbit anti-Peripherin
(Abcam), rabbit anti-pH 3 (1:250, Upstate). All primary antibodies
were detected by immunoﬂuorescence with secondary antibodies
from Jackson Immunoresearch or Molecular Probes except for anti-
Smad4 and anti-Mash1 staining, which were visualized by Tyramide
Signal Ampliﬁcation using the TSA Plus Fluorescence System from
Perkin Elmer (according to the manufacturer's manual) and by the
Vectastain method using NovaRed as a substrate (Vector Labora-
tories), respectively.
Cell culture
Cultures of neural crest explants were done as previously
described in Kleber et al. (2005). Deﬁned medium (SN) was prepared
as described in Greenwood et al. (1999) and supplemented with
50 ng/ml BMP for induction of Mash1. For differentiation of NCSCs to
smooth muscle cells, a deﬁned medium supplemented with chicken
embryonic extract (CEE) (referred to as standard medium (SM);
Stemple and Anderson, 1992) and 1 ng/ml TGF-β1 (PeproTech) was
used. In some experiments, differentiation to smooth muscle cells and
the autonomic lineage was achieved by culturing NCSCs in an
undeﬁned medium composed of standard medium with 10% FBS
(Invitrogen) and 5 μM Forskolin (Sigma) for 5–12 days.
ENS sphere cultures were obtained by dissociating gut from E11.5
mouse embryos with 1 mg/ml Collagenase I (Worthington) dissolved
in HBSS− (Gibco). The neural crest-speciﬁc neurosphere medium
contained DMEM-F12 glutamax (Gibco), 20 ng/ml bFGF (PeproTech),
1% N2 supplement (Invitrogen), 2% B27 supplement (Invitrogen),
50 μM β-mercaptoethanol, 1% Penicillin/Streptomycin (Invitrogen),
15% CEE, 35 ng/ml retinoic acid (Sigma), and 20 ng/ml IGF1
(PeproTech). The culture plates were coated with Poly (2-hydro-
xyethyl methacrylate) (Sigma) to prevent cells from adhering to the
plastic surface. Neurospheres were passaged every 6 days. Differentia-
tion of the neurospheres to the sympathetic lineage was done in
undeﬁned medium as described above. BMP (PeproTech) was used at
a concentration of 25 ng/ml and Noggin (PeproTech) at 100 ng/ml.
Results
Smad4 is required for survival but apparently not for fate acquisition of
neural crest-derived smooth muscle cells
To inactivate Smad4 in the neural crest, the Smad4 MH2 domain
required for binding of phosphorylated R-Smads and other transcrip-
tion factors was conditionally deleted by Wnt1-Cre (Fig. 1A) (Yang et
al., 2002; Jia et al., 2007; Ko et al., 2007). Recombination of this
conditional allele is reported to result in a Smad4 null allele (Yang et
al., 2002). Cre activity was monitored by recombination-dependent β-
Galactosidase (β-Gal) expression in the ROSA 26 reporter (R26R)
strain (Soriano, 1999). Wnt1-Cre-mediated recombination efﬁciently
deletes genes of interest in virtually all neural crest cells (Lee et al.,
2004; Wurdak et al., 2005). Accordingly, Smad4 protein expression
was abolished in mutant neural crest derivatives, such as in the
pharyngeal arches (Figs. 1B, C). Premigratory and emigrating Smad4-
Fig.1. Premigratory and emigrating neural crest cells are not affected by disrupted Smad
signaling. (A) Exon 8 of Smad4 was conditionally deleted by activity of the Wnt1-Cre
transgene, yielding a truncated form of Smad4 protein lacking the MH2 domain and
resulting in a null mutant. (B, C) Immunohistochemistry of Smad4 in pharyngeal arch 1.
In control embryos Smad4 was abundantly expressed (B), while the protein was
abolished in neural crest-derived tissue in Smad4 conditional knock out (cko) embryos
(C). Arrow in C points to ectodermal and arrowhead to endodermal tissues that were
Smad4 positive, since these tissues are not neural crest derived and not recombined.
(D, E) Immunohistochemistry for the neurotrophin receptor p75 (red) and Sox10
(green). DAPI (blue), (nt) neural tube. (F, G) Ngn2 in situ hybridization. Smad4-deﬁcient
NCSCs at E9.5 express the early neural crest markers p75, Sox10, and Ngn2 at normal
levels. Arrows in (D, E) show p75 positive neural crest cells delaminating from the roof
plate of the neural tube and arrow heads point to p75/Sox10-expressing migratory
NCSCs. In (F, G), Ngn2-positive neural crest cells emigrate from the dorsal part of the
neural tube in control and mutant. (H, I) In vivo fate mapping of neural crest cells using
R26R on whole mount embryos at E10.5. Smad4-mutant neural crest cells reach their
postmigratory targets, such as the pharyngeal arches (white arrowhead), DRGs (arrow),
and the gut (black arrowhead). Scale bars: (C) 75 μM, (G) 50 μM, (I) 2 mm.
Fig. 2. Cell death in areas of smooth muscle development upon Smad4-deletion in
neural crest cells. (A–F and I, J) In vivo fate mapping by R26R. (G, H, K and L)
Immunostaining for SMA (green) along with TUNEL labeling for apoptosis (red). (A, B)
Whole heart at E10.5. The heart of the Smad4 mutant (B) shows a shortened outﬂow
tract. (C–H) Formation of smooth muscle cells (arrows in G, H) is found in the β-Gal
positive (X-Gal) neural crest-derived tissue of the aortic sac (square in C, D enlarged in
E, F), while apoptosis is barely detectable yet (arrow heads in H). (E, G) and (F, H),
respectively, are adjacent sections. Note strong SMA staining in β-Gal negative tissue
not derived from the neural crest marked by dotted lines in (E–H). (K, L) SMA formation
and TUNEL in the area of the neural crest-derived fourth pharyngeal arch artery (see
fate mapping on adjacent sections in I, J). Note increased apoptosis in the mutant neural
crest-derived tissue (arrow heads) and decreased SMA expression, compared to control
tissue (arrow). (BA1) branchial arch 1, (da) dorsal aorta, (la) left atrium, (lo) lining of
the laryngeal oriﬁce, (lv) left ventricle, (OFT) cardiac outﬂow tract, (PAA) pharyngeal
arch artery, (ra) right atrium, (rv) right ventricle. Scale bars: (B) 0.5 mm, (D) 200 μM,
(H) and (L) 100 μM.
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markers Sox10 and p75 (Figs.1D, E) (Paratore et al., 2001) as well as of
Neurogenin 2 (Ngn2), which is expressed in the early wave of the
sensory lineage in the trunk (Figs. 1F, G) (Sommer et al., 1996). At
E10.5, in vivo fate mapping of β-Gal-expressing cells revealed normal
migration of Smad4-deﬁcient neural crest cells to various locations,
including the pharyngeal arches, dorsal root ganglia (DRG), and the
gut (Figs. 1H, I). However, in accordance with earlier reports,
conditional inactivation of Smad4 resulted in severe craniofacial
defects (data not shown; Ko et al., 2007) and a shortened cardiacoutﬂow tract (Figs. 2A, B) (Jia et al., 2007). This phenotype was
accompanied by massive apoptosis in craniofacial structures and the
pharyngeal apparatus (Ko et al., 2007), as illustrated by extensive
TUNEL labeling in the area of the fourth pharyngeal arch artery in
mutant embryos at E11 (Figs. 2K, L). Mutant embryos were obtained at
expected Mendelian ratios until E12. After E12.5, however, we were
unable to collect anymutants, revealing a highly penetrant phenotype.
BMP2 and TGFβ are able to instructively promote a smooth muscle
fate in cultured NCSCs (Shah et al., 1996). To address whether these
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crest cells in vivo, we performed immunostaining for smooth muscle
actin (SMA) on sections of conditional knock out embryos, in which
neural crest derivativesweremarked byβ-Gal expression. Intriguingly,
early formation of smooth muscle was found in mutant neural crest-
derived tissue to a similar extent as in the control, such as the aortic sac
and the third pharyngeal arch artery at E10.5, when apoptosis was still
scarcely detectable in these particular areas (Figs. 2C–H, and data not
shown). In agreement with Jia et al. (2007) we found in the same
embryos strongly increased apoptosis in the branchial arches.
Although clearly reduced and accompanied by massive cell death,
SMA was still detectable in mutant neural crest-derived pharyngeal
arch arteries from E11 onwards (Figs. 2I–L; data not shown).
Although smooth muscle formation was detectable in conditional
knock out embryos, it is difﬁcult to address in vivo whether loss of
Smad4 interferes with smooth muscle fate acquisition, thereby
leading to increased cell death, or whether Smad4-deﬁcient neural
crest cells are able to choose a smooth muscle fate, but then require
Smad4 for survival. Therefore, to address this question on the cellular
level, we used NCSC cultures, in which TGFβ family factors have been
shown to promote smooth muscle fate decision (Shah et al., 1996).
Neural crest explant cultures were generated from neural tubes of
control and conditional Smad4-knock out embryos at E9.5 (Hari et al.,
2002). Sox10/p75-positive NCSCs emigrated from both control and
mutant neural tubes (Figs. 3A, B). Virtually all of the control cells were
positive for Smad4, while Smad4 protein expression was completely
lost in mutant cultures (Figs. 3C–F). To promote differentiation,
explants were cultured in standard medium containing chicken
embryonic extract (CEE) in the presence or absence of TGF-β1, as
described in Shah et al. (1996). While in control cultures, smooth
muscle formation was strongly increased by the addition of TGFβ,
Smad4-deﬁcient cultures were unable to respond to this growth
factor and displayed only limited SMA immunostaining (Figs. 3G–J).
Thus, TGFβ acts via canonical Smad signaling to instruct NCSCs to
adopt a smooth muscle fate.
Given the presence of SMA-positive neural crest-derived cells in
Smad4-conditional mutants (Figs. 2E–L), we next asked whether
signals other than TGFβ/Smad4 might be able to induce smooth
muscle formation in neural crest cells. To this end, explants were
incubated in conditions permissive for smooth muscle generation
(Stemple and Anderson, 1992) by culture in standard medium
containing fetal bovine serum (FBS) and forskolin, which leads to
enhanced cAMP production. Intriguingly, under these conditions,
smooth muscle cells readily formed in both control and Smad4-
deﬁcient explants, and at 5 days of incubation there was no obvious
difference in the extent of SMA expression (Figs. 3K, L). Thereafter,
however, mutant smooth muscle cells began to die, and at 9 days of
culture only few smooth muscle cells remained, even though many
other, SMA-negative cells were still present in Smad4-deﬁcient
explants (Figs. 3M, N). In contrast, control explants at 9 days
contained large numbers of smooth muscle cells. These data indicate
that Smad4 activity is not an absolute prerequisite for smooth muscle
fate acquisition and differentiation per se, but controls survival and
maintenance of these cells once formed from neural crest cells.Fig. 3. Smad4 is required for survival but is not a prerequisite for fate acquisition of
neural crest-derived smoothmuscle cells. Immunocytochemistry of neural crest cells in
neural tube explant cultures. (A, B) Smad4-deﬁcient NCSCs express the neural crest
markers Sox10 (green) and p75 (red), as do control cultures. (C–F) Absence of Smad4
(red) expression in mutant neural crest explants. (E, F) Same frame as in (C, D), but
with DAPI (blue) staining revealing cell nuclei. (G–J) While control explants produce
more smooth muscle cells (SMA (red)) in response to TGFβ, Smad4-deﬁcient NCSCs do
not respond to TGFβ when cultured in standard medium. (K–N) After 5 days (5 d) in
standard medium containing FBS and forskolin, mutant NCSCs are able to acquire a
smooth muscle fate (K, L), but the smooth muscle cells were dependent on Smad4 for
survival. After 9 days in culture there are hardly any smooth muscle cells left in mutant
explant cultures (M, N). Scale bars: (J) 50 μM, (N) 250 μM.Smad4 controls sensory neuronal fate decision in trigeminal but not
dorsal root ganglia
Apart fromnon-neural lineage regulation, TGFβ family factors have
also been implicated in neuronal lineage generation from the neural
crest. At stages of ongoing neurogenesis (E10.5), Smad1/5/8
(mediating BMP signaling) and Smad2/3 (mediating TGFβ signaling)
Fig. 4. Smad4 is required for sensory lineage decision in the trigeminal ganglia. (A, B, K,
L) Immunohistochemistry and TUNEL of trigeminal ganglia and DRG at E10.5. There are
no differences between mutant and control tissue with regard to proliferation (pH 3,
white), apoptosis (TUNEL, red), and Sox10 expression (green). (C–J, M–Y) In situ
hybridizations. (C, D) Ngn1 is almost absent in the Smad4-mutant trigeminal ganglia at
E10.5, which results in deﬁcient expression of TrkA at E11.5 (E, F). (G–J) TrkB and TrkC
expression in the trigeminal ganglia are not affected by the loss of Smad4. Similarly,
Ngn1 and TrkA, B and C are normally expressed inmutant DRGs (M–T). (U–Y) Ngn1 and
TrkA are expressed in trigeminal ganglia of conditional Tgfbr2 knock out embryos at
E11.5, which shows that the Ngn1–TrkA sensory lineage is dependent on Smad signaling
via BMP ligands. Scale bars: (J) and (Y) 100 μM, (T) 50 μM.
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shown; Chuva de Sousa Lopes et al., 2004). Moreover, BMP signaling
has been shown to control trigeminal ganglia size and patterning
(Hodge et al., 2007; Ko et al., 2007). To address whether these ﬁndings
reﬂect a role of Smad signaling in controlling sensory cell survival, we
ﬁrst assessed apoptosis in trigeminal ganglia and DRG of control and
Smad4-conditional knock out embryos at E10.5 and E11.5. Unlike in
mesenchymal neural crest derivatives including smooth muscle, loss
of Smad4 did not affect cell survival in the sensory lineage (Figs. 4A, B,
K, L and data not shown). Likewise, proliferationwas unchanged in the
mutant.
Sensory neuronal fate decision involves the proneural transcrip-
tion factors Neurogenin (Ngn) 1 and 2, with Ngn1 regulating the
generation of the TrkA-positive subpopulation of sensory neurons and
Ngn2 the generation of TrkB/C-expressing sensory neurons (Ma et al.,
1999). Intriguingly, we found that in the trigeminal ganglia at E10.5
Ngn1 expression requires Smad4, while it is independent of Smad4 in
DRG and the vestibulo-cochlear ganglia (Figs. 4C, D, M, N and data not
shown). Impaired Ngn1 expression in mutant trigeminal ganglia was
not due to delayed development, as it was also strongly reduced at
E11.5 (data not shown). Accordingly, TrkA but not TrkB/Cwas virtually
absent in Smad4-deﬁcient trigeminal ganglia, indicating lack of this
particular sensory lineage upon Smad signal inactivation (Figs. 4E–J).
In contrast, TrkA, B, and C were normally expressed in mutant DRG
(Figs. 4O–T).
To address whether it is canonical TGFβ or BMP signaling that is
involved in fate acquisition of the TrkA sensory lineage in trigeminal
ganglia, the expression of Ngn1 and TrkAwere analyzed in conditional
knock out embryos, in which Tgfbr2 – encoding an essential receptor
for TGFβ but not BMP signaling – had been ablated in the neural crest
(Leveen et al., 2002;Wurdak et al., 2005). Unlike in conditional Smad4
knock out embryos, Ngn1 and TrkA expressionwere not affected in the
trigeminal ganglia of Tgfbr2 mutants (Figs. 4U–Y). Given that cell
survival and proliferation were not altered in conditional knock out
sensory ganglia, our data indicate that BMP/Smad signaling is
involved in sensory neuronal fate decision speciﬁcally in trigeminal
ganglia.
BMP/Smad4-independent autonomic neurogenesis
In neural crest cell cultures, TGFβ as well as BMP can promote
autonomic neurogenesis in an instructive and context-dependent
manner (Shah et al., 1996; Hagedorn et al., 1999, 2000). Moreover,
BMP signaling in chicken regulates autonomic ganglia formation,
along with expression of the transcription factors Mash1 and Hand2
that control autonomic neurogenesis (Guillemot et al., 1993; Sommer
et al., 1995; Reissmann et al., 1996; Schneider et al., 1999; Howard
et al., 2000). Thus, should Smad signaling be involved in promoting
autonomic fate decision in vivo, one would expect reduced Mash1
expression in Smad4-deﬁcient autonomic ganglia. In contrast, how-
ever, loss of Smad4 in sympathetic ganglia at E10.5 (Figs. 5A, B) was
not associated with altered Mash1 expression, although the mutant
ganglia were somewhat smaller than in the control (Figs. 5E, F).
Similarly, Mash1 was not affected in the mutant enteric nervous
system (ENS) (data not shown). Likewise, expression of Hand2 was
present in Smad4-deﬁcient sympathetic ganglia at E10.5 (Figs. 5G, H).
Moreover, neuronal differentiation occurred normally, as pan-neuro-
nal markers such as βIII-tubulin as well as the autonomic differentia-
tion marker tyrosine hydroxylase (TH) were readily detectable in
ganglia lacking Smad4 (Figs. 5C, D and K, L). Of note, however, the size
of sympathetic gangliawas clearly reduced in themutant as compared
to the control at E11 (Figs. 5I–L).
At ﬁrst sight, our in vivo data seem to contradict previous ﬁndings
obtained in vitro pointing to instructive roles of TGFβ family factors in
autonomic fate acquisition. One possibility explaining this discrepancy
might be that TGFβ/BMP promotes autonomic neurogenesis inde-pendently of Smad4 by a non-canonical pathway. In BMP2-treated
NCSC explant cultures incubated in deﬁned medium, Mash1 expres-
sion was completely abolished in the absence of Smad4, while it was
strongly induced in control cultures (Figs. 6A, B). Thus, persistence of
Mash1 expression in ganglia lacking Smad signaling might indicate
the existence of other signaling cues with the potential to induce
autonomic neurogenesis. In vitro, elevated levels of cAMP (induced by
Fig. 5. Differentiation of NCSCs to autonomic neurons is independent of Smad4. (A–D)
Immunohistochemistry. The pan-neuronal marker βIII-tubulin (green) is expressed in
the sympathetic ganglia at E10.5 in the absence of Smad4 protein (red), as shown on
adjacent sections. The sympathetic ganglia are marked by dashed lines in (A and B).
(E–H) In situ hybridizations. In the mutant, the autonomic markers Mash1 and Hand2
are expressed at normal levels at E10.5. (I–L) Immunohistochemistry. At E11, mutant
sympathetic ganglia are smaller than control ganglia, but neurons lacking Smad4 (red;
arrow in J) express the autonomic differentiation marker TH (green). (I, K) and (J, L) are
adjacent sections. Scale bar: 50 μM.
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(Sarkar and Howard, 2006). Therefore, we incubated NCSCs in
standard medium supplemented with FBS and forskolin, which is
permissive (but not instructive) for an autonomic fate (Sommer et al.,
1995). Strikingly, both Smad4-deﬁcient NCSCs that have emigrated
from the neural tube as well as mutant NCSCs derived from the ENS
were able to give rise to Mash1-positive cells under these conditions
(Figs. 6C, D and G, H). Moreover, fully differentiated neuroﬁlament
(NF)160-positive autonomic neurons were generated in control and
mutant NCSC explant cultures upon prolonged incubation for 12 days
(Figs. 6E, F). Likewise, both control and mutant ENS NCSCs readily
gave rise to neurons double-positive for Peripherin and TH (Figs. 6I, J
and data not shown). To assess whether neurogenesis could occur
because of incomplete Cre-mediated recombination, we performed
fate mapping of ENS NCSCs carrying a recombined R26R allele. These
cells can be tracked by a typically dotted staining for β-Gal (Lutolf
et al., 2002). Both in control and mutant cultures, virtually all TH-
positive neurons expressed β-Gal (green labeling in Figs. 6I, J),
demonstrating that appearance of TH-expressing neurons in the
absence of Smad4 was not simply due to inefﬁcient gene deletion.
Similarly to the in vivo situation, however, ganglia-like structures
obtained in cell cultures were smaller in the mutant than in the
control.
In deﬁned medium, addition of Noggin, an efﬁcient inhibitor of
BMP signaling (Zimmerman et al., 1996), reversed the neurogenic
effect of BMP, abolishing Mash1 expression in NCSCs from the ENS
(Figs. 6K–M). To conﬁrm that neurogenesis can be promoted from
NCSCs in a BMP/Smad-independent manner, we exposed control and
Smad4-mutant NCSCs from the ENS in FBS/forskolin-containing
medium to Noggin. When incubated in this complex medium,
Smad4-deﬁcient NCSCs were able to generate Mash1-positive pro-
genitors and Peripherin/TH-double-positive neurons, even in the
presence of Noggin (Figs. 6N–Q). Thus, factors other than BMP/Smad
can promote generation of Mash1-dependent TH-positive neurons.
Again, however, mutant cultures gave rise to fewer TH-positive
neurons as compared to control cultures, suggesting that in the
chosen context Smad signaling might control numbers of neurons
rather than acquisition of their fate.
Smad4 controls proliferation of autonomic and ENS neuronal progenitor
cells
The size reduction of Smad4-deﬁcient autonomic ganglia in vivo
and of ganglia-like structures in mutant cell cultures might reﬂect a
role of Smad signaling in the control of cell survival, as in neural crest-
derived smooth muscle, or in proliferation. To address this point we
ﬁrst performed TUNEL labeling for programmed cell death in control
and conditional knock out embryos at E10.5 and quantiﬁed the
number of apoptotic cells in sympathetic ganglia. Apoptosis was low
at this stage, and there was no change in the number of apoptotic cells
upon loss of Smad4 (Fig. 7A). In contrast, staining for the mitotic
marker Ki67 revealed a highly signiﬁcant decrease in the number of
proliferative NF160-positive cells in Smad4-deﬁcient as opposed to
control sympathetic ganglia at E11.5 (Figs. 7B–D). Thus, Smad
signaling regulates proliferation of autonomic neuronal progenitors
in vivo.
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neuronal progenitors, but they did not directly address whether Smad
signaling might also control stem cell self-renewal. To address this
issue, and to conﬁrm the in vivo data by an independent approach, we
generated non-adhesive ENS sphere cultures from control and
conditional knock out gut at E11.5 (Kruger et al., 2002; Fuchs et al.,
2009). In this system, stem cell self-renewal can be monitored by
serial sphere passaging, while the sphere size is indicative of
progenitor cell proliferation. Self-renewal as assessed by determining
the ratios between secondary per primary and tertiary per secondary
sphere numbers was not affected upon Smad4 inactivation (Fig. 7E).
Accordingly, both control and mutant spheres could be serially
propagated over several passages (Fig. 7H). However, in all passages,
the average sphere size was signiﬁcantly reduced in the Smad4-
deﬁcient cultures. In particular, spheres with a diameter larger than
100 μmwere reduced bymore than 70% in quaternarymutant spheres,
whereas in the same passage the number of spheres with a diameter
smaller than 50 μm was strongly increased by 260% (Fig. 7I). In sum,
proliferation of autonomic and ENS progenitor cells, but not of
postmigratory NCSCs, is controlled by Smad signaling.
Discussion
Experimental culture systems of neural crest cells have success-
fully been used not only to determine the self-renewal capacity of
NCSCs, but also to identify growth factors instructively promoting
stem cell maintenance and lineage decisions (Le Douarin and Dupin,
2003; Fuchs and Sommer, 2007). Based on cell culture experiments,
TGFβ family factors have been implicated in both non-neural and
neuronal fate decisions by NCSCs (Shah et al., 1996; Hagedorn et al.,
1999; Lo et al., 2002; Ota and Ito, 2006). Several studies demonstrated
an in vivo role of TGFβ factor signaling in the generation of non-neural
as well as neuronal derivatives from the neural crest (Schneider et al.,
1999; Ito et al., 2003; Kaartinen et al., 2004; Stottmann et al., 2004;
Ittner et al., 2005; Wurdak et al., 2005; Choudhary et al., 2006; Dudas
et al., 2006; Wang et al., 2006; Hodge et al., 2007; Jia et al., 2007; Ko
et al., 2007; Mancini et al., 2007). However, the implication of TGFβ
factors in actual fate choice by neural crest cells in vivo has remained
unclear. Here we found that inactivation of canonical TGFβ factor
signaling in neural crest cells by conditional deletion of Smad4 has
surprisingly little effects on neural crest cell fate decisions in vivo, with
the notable exception of sensory neuronal fate acquisition in
trigeminal ganglia. In contrast, sensory lineages in DRG were
unaffected upon Smad4 deletion. Likewise, Smad4-deﬁcient neural
crest cells were able to adopt both an autonomic neuronal and a
smooth muscle fate, although the mutation inﬂuenced proliferation
and survival, respectively, in these lineages. A possibly involvement of
Smad signaling in fate acquisition might not be apparent in the
mutants in vivo, given that in culture compensatory mechanisms can
promote autonomic and smooth muscle fates independently of
Smad4. Overall our data reveal multiple roles of Smad signalingFig. 6. Compensatory factors inducing NCSCs to differentiate into autonomic neurons in
the absence of BMP/Smad4 signaling. (A–F) Neural crest explant cultures, (G–Q) plated
ENS spheres. (A, B) Mash1 induction is dependent on canonical BMP signaling when
NCSCs are differentiated in deﬁned medium (SN) with BMP. (C–F) In contrast,
expression of Mash1 (dark grey) and NF160 (green) is independent of Smad4 signaling
in medium (SM) containing FBS and forskolin. (G–J) Control as well as Smad4-deﬁcient
ENS cells expressMash1 (G–H) and differentiate into neurons positive for both TH (red)
and Peripherin (white) (I, J) in medium with FBS and forskolin. β-Gal (green) shows
that Cre-mediated recombination has taken place. Inset, magniﬁcation of neuron
(arrow) displayed in (J). Arrowheads, β-Gal staining. (K–M) Noggin prevents BMP-
induced Mash1 expression in ENS sphere cells. ENS spheres in deﬁned medium display
some Mash1-positive cells, revealing endogenous BMP activity (K). When exposed to
BMP, Mash1 expression is strongly increased (L), but Noggin inhibits both the
endogenous and the BMP-induced expression of Mash1 (M). (N–Q) Both control and
Smad4-mutant ENS cells cultured in medium containing FBS, forskolin, and Noggin
are able to give rise to neuronal cells, as shown by staining for Mash1 (N, O), and TH
(red), Peripherin (white), and β-Gal (green). Scale bar: 50 μM.
Fig. 7. Decreased proliferation in sympathetic ganglia and ENS progenitor cells in the
absence of Smad4. (A) Equal extent of apoptosis in control and Smad4-mutant
sympathetic ganglia at E10.5. TUNEL-positive cells in ganglia were counted, and the
ratio between apoptotic cells and all ganglionic cells was calculated. Control (dark grey
bars), mutant (light grey bars). (B–D) There are signiﬁcantly less neuronal progenitors
in cell cycle in mutant than in control sympathetic ganglia. All NF (green) positive cells
and all NF/Ki67 (red) double positive cells were counted (C, D). To get the percentage of
proliferating neuronal progenitors, the ratio between double positive cells and all NF-
positive cells was determined. (E–I) ENS neurosphere assay. (E) Self-renewal is not
affected in Smad4-mutant spheres. (F, G) Examples of average-sized control andmutant
spheres. (H) The difference in size between control and mutant ENS spheres is
statistically signiﬁcant from the ﬁrst to the fourth passage. (I) Distribution of sphere
sizes in ﬁrst and fourth passage. There is a signiﬁcant increase in the number of small
spheres (less than 50 μM) and a decrease in spheres sized between 100–150 μM in the
mutant. (⁎⁎⁎, pb0.05). Scale bars: (D) 30 μM and (G) 50 μM.
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neural crest-derived lineages.
Smad4-independent generation of neural crest-derived smooth muscle
cells
Smad4 inactivation in the cranial neural crest results in many
severe cardiovascular and craniofacial defects, as has been described
before in detail (Jia et al., 2007; Ko et al., 2007). Similar anomalies
were also observed after conditional ablation of other TGFβ signaling
components, including TGFβ family ligands and receptors (Wurdak
et al., 2006). For instance, ablation of Tgfbr2 in neural crest cells leads
to various cardiovascular and craniofacial malformations reminiscent
of DiGeorge syndrome (Wurdak et al., 2005). Moreover, the shortened
outﬂow tract of Smad4 mutants resembles the phenotype found in
embryos lacking the BMP receptors Alk2 and Alk3 in neural crest cells
and their derivatives (Kaartinen et al., 2004; Stottmann et al., 2004).
However, the phenotypes in these cases were less severe and not
accompanied by massive cell death, as observed in conditional Smad4
knock out embryos. In contrast, ablation of the TGFβ type 1 receptor
Alk5 in neural crest cells resulted in craniofacial and cardiac outﬂow
tract phenotypes very similar to the ones found upon neural crest-
speciﬁc Smad4 inactivation (Dudas et al., 2006; Wang et al., 2006). In
particular, Alk5 deﬁciency was also associated with extensive cell
death in neural crest-derived tissue, suggesting that disturbed
signaling by ligands that act via Alk5 (such as, for instance, GDF11)
might mainly contribute to the phenotype observed in Smad4
mutants. This does not exclude further functions of Smad4 in
craniofacial and cardiovascular development, including BMP-
mediated neural crest cell migration to the outﬂow tract or
proliferation promoted by TGFβ during palatogenesis (Ito et al.,
2003; Kaartinen et al., 2004; Sasaki et al., 2005).
Importantly, although smooth muscle differentiation appears to be
locally disturbed in some mouse lines lacking TGFβ signaling
components in neural crest cells (Kaartinen et al., 2004; Wurdak et
al., 2005), absence of canonical TGFβ factor signaling is compatible
with smooth muscle cell formation per se (Figs. 2 and 3). In particular,
we show that TGFβ-induced smooth muscle formation from NCSCs in
culture indeed requires Smad4, but that other pathways, as activated
by serum factors, are able to promote smooth muscle formation even
in the absence of Smad4. These factors could act via RhoA that in
culture canmediate TGFβ-induced smoothmuscle formation (Chen et
al., 2006). However, conditional inactivation of RhoA in vivo does not
produce any overt neural crest lineage deﬁciencies during develop-
ment, inconsistent with a role of RhoA signaling in smooth muscle
formation (Falk S., Brakebush C., and Sommer L., unpublished). This
function might be fulﬁlled by signaling through the TGFβ co-receptor
endoglin that is required for smooth myogenesis in culture and
promotes increased smooth muscle formation upon overexpression,
possibly in a Smad4-independent manner (Mancini et al., 2007). Cells
having acquired a smooth muscle fate in culture, however, are
dependent on Smad signaling for survival. These ﬁndings are
compatible with our in vivo data, since smooth muscle cells are
present around the aortic sac and arteries in Smad4-deﬁcient
embryos, becoming reduced only after initial formation. Thus, in
vivo development of smooth muscle in neural crest derivatives
appears to involve both canonical TGFβ factor signaling as well as
alternative signaling pathways.
Signaling pathways promoting sensory fate acquisition in NCSCs
An established key player in sensory fate decision by early NCSCs is
canonical Wnt/β-catenin signaling (Kleber and Sommer, 2004)
NCSCs, in which β-catenin has been conditionally ablated, fail to
generate both a ﬁrst wave of Ngn2-dependent TrkB/C-positive
sensory neurons and a second wave of Ngn1-dependent TrkA-positive
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of β-catenin in the neural crest promotes a sensory fate in dorsal root
and cranial ganglia at the expense of all other possible neural crest cell
fates in vivo (Lee et al., 2004). Thereby, Wnt/β-catenin provides an
instructive signal for sensory fate speciﬁcation, as shown in NCSC
cultures. Further cell culture experiments suggested that low doses of
BMP2/4 could also promote generation of Ngn2- and Ngn1-positive
cells and sensory neuronal differentiation in neural crest cells from
trunk neural tube (Lo et al., 2002; Ota and Ito, 2006). However, our
study does not support an in vivo role of TGFβ factor signaling in
sensory neurogenesis in the trunk, as neither the generation of TrkB/
C- nor of TrkA-expressing DRG neurons was affected in conditional
Smad4-knock out embryos.
Intriguingly, Smad signaling does play a role in sensory fate
decision in trigeminal ganglia. In these cranial ganglia, neural crest-
derived cells adopting a sensory fate express Ngn1 but not Ngn2
(Sommer et al., 1996; Ma et al., 1999). Ngn1 expression as well as the
generation of TrkA-positive sensory neurons depends on Smad4,
while Smad signaling does not inﬂuence cell survival or proliferation
(Fig. 4). Thus, unlike in DRG, sensory fate speciﬁcation in trigeminal
ganglia is controlled by Smad activity. The ligand mediating this effect
is a BMP factor rather than a TGFβ isoform, because sensory
neurogenesis was normal in trigeminal ganglia lacking Tgfbr2, which
mediates TGFβ but not BMP signaling. An earlier study by Hodge et al.
(2007) revealed a role of Smad4 and retrograde BMP signaling in
trigeminal ganglia patterning and the establishment of appropriate
central projections. We propose that these patterning and projections
defects, apparent in Wnt1-Cre/Smad4 mutant embryos at E11.5
(Hodge et al., 2007), might involve impaired sensory fate decision
and consequent loss of Ngn1-expressing neuronal progenitors, as
revealed in the present work in mutant embryos at E10.5.
Smad signaling regulates proliferation but not fate acquisition of
autonomic neuronal progenitor cells
Based on multiple evidence obtained in vitro and in vivo, a strong
point was made that TGFβ factor signaling regulates autonomic fate
speciﬁcation (reviewed in Huber, 2006). BMP2/4 and, depending on
the cellular context, TGFβ were shown to promote autonomic
neurogenesis in NCSC cultures (Shah et al., 1996; Hagedorn et al.,
1999, 2000). In addition, BMPs are expressed in the dorsal aorta
close to the site of sympathetic ganglia formation (Reissmann et al.,
1996), and expression of Mash1 as well as Hand2, both key players
in autonomic neurogenesis, can be regulated by BMPs (Shah et al.,
1996; Howard et al., 2000). Functionally, local overexpression of BMP
in chicken embryos increased the size of adjacent sympathetic
ganglia and even led to the appearance of ectopic cells with a
sympathetic phenotype (Reissmann et al., 1996). In contrast,
inhibition of BMP signaling by Noggin reduced sympathetic ganglion
size, although initial ganglia formation was not affected (Schneider
et al., 1999). Our data now provide a novel, alternative explanation
for these results: Rather than inﬂuencing an autonomic fate choice,
canonical TGFβ factor signaling controls sympathetic ganglion size
by regulating proliferation of autonomic neuronal progenitors.
Indeed, Mash1, Hand2 as well as TH were expressed in sympathetic
ganglia formed by Smad4-deﬁcient neural crest derived cells (Fig. 5),
although the mutant ganglia were considerably smaller than their
wild type counterparts. Culture experiments in deﬁned medium
conditions revealed that, similar to the action of TGFβ in smooth
muscle formation, BMP2 can promote Mash1 expression and
autonomic neurogenesis in a Smad-dependent manner (Fig. 6).
However, at least in culture, other factors can compensate for BMP
signaling and induce the generation of autonomic neurons even in
neural crest cells lacking Smad4 (Nakajima et al., 2008 and this
study). Thereby, compensatory cues do not rely on non-canonical
BMP signaling, since Mash1-dependent neurogenesis can also occurin the presence of Noggin that inhibits BMP signaling by sequester-
ing the ligand. Such compensatory mechanisms might also explain
why production and maintenance of early migratory NCSCs is
apparently not affected in vivo in conditional Smad4 knock out
embryos. This is despite the reported role of BMP in NCSC
delamination and expansion in culture (Sela-Donenfeld and Kalcheim,
1999; Kleber et al., 2005) and the fact that the Smad4-mutant NCSC
explants could not be maintained in vitro (Büchmann-Møller S. and
Sommer L., unpublished). cAMP and protein kinase A (PKA) activation
have been implicated before in BMP/Smad-independent differentia-
tion of sympathetic neurons in vitro (Liu et al., 2005), although cAMP is
believed to represent a permissive rather than an instructive cue
(Sarkar and Howard, 2006). According to these studies, however, PKA
modulates Hand2 on the posttranslational level and would therefore
not compensate for BMP signaling to regulateHand2mRNAexpression
in Smad4-conditional knock out embryos (in which we see normal
expression of Hand2 mRNA by in situ hybridization; Fig. 5).
Furthermore, deletion of the gene encoding CREB (cAMP response
element-binding protein), which mediates cAMP signaling, does not
affect autonomic neuronal fate speciﬁcation, but rather neuronal cell
survival (Lonze et al., 2002).We conclude that canonical BMP signaling
is either not at all involved in autonomic fate decision in vivo or is
compensated for this function in Smad4 mutants by factors that
remain to be identiﬁed.
The size of sympathetic ganglia is determined ﬁrst by progenitor
cell maintenance and proliferation, followed by proliferation of cells
that have already acquired sympathetic neuronal traits (Tsarovina
et al., 2008). Thus, unlike for instance in sensory ganglia where
differentiation is coupled to cell cycle exit, proliferative neuronal cells
contribute to a large extent to sympathetic ganglia development.
While at early developmental stages Notch signaling controls
maintenance of undifferentiated progenitor cells (Tsarovina et al.,
2008), we identiﬁed in the present study Smad signaling as a crucial
regulator of the sympathetic neuronal pool size. Indeed, the reduced
size of sympathetic ganglia in Smad4-conditional mutants is brought
about by signiﬁcantly decreased proliferation of neuronal cells in the
ganglia, while cell death was unaffected (Fig. 7). Likewise, progenitor
proliferation but not NCSC self-renewal was affected in Smad4-
deﬁcient neural crest-derived cells from the ENS. Smad-dependent
proliferation of ENS cells might be linked to the migration defects and
hypoganglionosis observed upon BMP signal inactivation, and
giant ganglia formation found upon BMP overexpression in the gut
(De Santa Barbara et al., 2005; Goldstein et al., 2005).
The role of Smad signaling in neuronal progenitors of the
autonomic and ENS lineages, rather than in undifferentiated NCSCs is
different from the reported activities of TGFβ and Smad in controlling
self-renewal by hematopoietic and midbrain neuroepithelial stem
cells (Karlsson et al., 2007; Falk et al., 2008). This underlines the cell
type- and context-speciﬁc functions elicited by canonical TGFβ factor
signaling. During neural crest cell development, Smad signaling is
associated with multiple cellular processes that include smooth
muscle survival, sensory fate decision in trigeminal ganglia, and
proliferation of autonomic neurons. How these Smad-dependent
processes are further modulated in vivo by other signaling pathways,
including non-canonical TGFβ/BMP signaling and TGFβ factor-inde-
pendent pathways eliciting similar and partially overlapping effects,
remains to be elucidated.
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